ITGB3 Gene Thrombocytopenia Neonatal Alloimmune Genetic Test sale cost 4400 AED
JAK3 Gene SCID Autosomal Recessive T Negative B Positive Type Genetic Test sale cost 4400 AED JAK3 Gene SCID Autosomal Recessive T Negative B Positive Type Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
IGHM Gene Agammaglobulinemia Type 1 Autosomal Recessive Genetic Test sale cost 4400 AED IGHM Gene Agammaglobulinemia Type 1 Autosomal Recessive Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

ITGB3 Gene Thrombocytopenia Neonatal Alloimmune Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The ITGB3 gene thrombocytopenia neonatal alloimmune genetic test is a specialized diagnostic procedure designed to identify mutations in the ITGB3 gene, which can lead to neonatal alloimmune thrombocytopenia (NAIT). NAIT is a rare condition where a pregnant mother’s immune system mistakenly targets the platelets of the fetus, leading to a low platelet count in the newborn, which can result in bleeding problems. This condition is of particular concern because it can cause serious health issues in affected newborns, including intracranial hemorrhage.

The test, available at DNA Labs UAE, involves analyzing the DNA of the fetus or newborn to detect any genetic variations in the ITGB3 gene that are known to contribute to the development of NAIT. This early detection is crucial for the timely management and treatment of the condition, potentially preventing its severe complications.

The cost of the ITGB3 gene thrombocytopenia neonatal alloimmune genetic test at DNA Labs UAE is 4400 AED. Given the specialized nature of the test and the significant implications of its results for affected families, it represents a critical investment in the health and well-being of the newborn. Families considering this test are advised to consult with a genetic counselor or a specialist in maternal-fetal medicine to fully understand the benefits, limitations, and potential outcomes of the testing process.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

ITGB3 Gene Thrombocytopenia Neonatal Alloimmune Genetic Test

Welcome to DNA Labs UAE, where we offer the ITGB3 Gene Thrombocytopenia neonatal alloimmune Genetic Test. This test is designed to diagnose and provide valuable information about the ITGB3 gene and its association with thrombocytopenia and neonatal alloimmune thrombocytopenia. Read on to learn more about this test.

Test Details

The ITGB3 gene is responsible for encoding a protein called integrin beta-3, which plays a crucial role in platelet function and clotting. Mutations in this gene can lead to a condition called thrombocytopenia, characterized by a low platelet count in the blood. Neonatal alloimmune thrombocytopenia (NAIT) is a specific type of thrombocytopenia that occurs in newborn babies. It is caused by maternal antibodies targeting platelet antigens inherited from the father. These antibodies cross the placenta and destroy fetal platelets, resulting in low platelet counts in the newborn.

Our ITGB3 Gene Thrombocytopenia neonatal alloimmune Genetic Test utilizes NGS (Next-Generation Sequencing) technology. NGS genetic testing allows for the simultaneous analysis of multiple genes or even the entire genome. In the context of ITGB3 gene thrombocytopenia and neonatal alloimmune thrombocytopenia, NGS genetic testing can identify mutations or variations in the ITGB3 gene or other relevant genes associated with these conditions. This helps in the diagnosis of these conditions and provides information about the genetic basis of the disease.

Additionally, NGS genetic testing can be used for carrier testing in families with a history of ITGB3 gene thrombocytopenia or neonatal alloimmune thrombocytopenia. It can identify individuals who carry mutations in the ITGB3 gene, even if they do not have the condition themselves. This information can be useful for family planning and reproductive decision-making.

Test Components and Price

Test Name: ITGB3 Gene Thrombocytopenia neonatal alloimmune Genetic Test

Components: NGS Technology

Price: 4400.0 AED

Sample Condition and Report Delivery

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Test Type and Doctor

Test Type: Hematology

Doctor: Hematologist

Test Department

Test Department: Genetics

Pre Test Information

Before undergoing the ITGB3 Gene Thrombocytopenia neonatal alloimmune Genetic Test, it is important to provide the clinical history of the patient. This includes information about the patient’s condition and any relevant family history. A Genetic Counselling session will also be conducted to draw a pedigree chart of family members affected by ITGB3 Gene Thrombocytopenia neonatal alloimmune NGS Genetic DNA Test gene ITGB3.

By offering this comprehensive ITGB3 Gene Thrombocytopenia neonatal alloimmune Genetic Test, we aim to provide accurate diagnoses, risk assessments, and genetic counseling to our patients. Contact DNA Labs UAE today to schedule an appointment or learn more about our services.

Test Name ITGB3 Gene Thrombocytopenia neonatal alloimmune Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Hematology
Doctor Hematologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for ITGB3 Gene Thrombocytopenia, neonatal alloimmune NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with ITGB3 Gene Thrombocytopenia, neonatal alloimmune NGS Genetic DNA Test gene ITGB3
Test Details

The ITGB3 gene is responsible for encoding a protein called integrin beta-3, which is involved in platelet function and clotting. Mutations in this gene can lead to a condition called thrombocytopenia, which is characterized by a low platelet count in the blood.

Neonatal alloimmune thrombocytopenia (NAIT) is a specific type of thrombocytopenia that occurs in newborn babies. It is caused by maternal antibodies targeting platelet antigens inherited from the father. These antibodies cross the placenta and destroy fetal platelets, leading to low platelet counts in the newborn.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that allows for the simultaneous analysis of multiple genes or even the entire genome. In the context of ITGB3 gene thrombocytopenia and neonatal alloimmune thrombocytopenia, NGS genetic testing can be used to identify mutations or variations in the ITGB3 gene or other relevant genes associated with these conditions. This can help in the diagnosis of these conditions and provide information about the genetic basis of the disease.

NGS genetic testing can also be used for carrier testing in families with a history of ITGB3 gene thrombocytopenia or neonatal alloimmune thrombocytopenia. It can identify individuals who carry mutations in the ITGB3 gene, even if they do not have the condition themselves. This information can be useful for family planning and reproductive decision-making.

Overall, NGS genetic testing for ITGB3 gene thrombocytopenia and neonatal alloimmune thrombocytopenia can provide valuable information for diagnosis, risk assessment, and genetic counseling.

SKU: TEST-3960 Category:

Related products